2-Oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile

Catalog No. :
ACBFMJ328
CAS No. :
2894063-44-4
Molecular Formula :
C13H14BF3N2O3
Molecular Weight :
314.07

IUPAC Name:2-oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile

2-Oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile
IUPAC Name2-oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile
Molecular FormulaC13H14BF3N2O3
Molecular Weight314.07
SMILESN#CC1=CC(B2OC(C)(C)C(C)(C)O2)=C(C(F)(F)F)NC1=O
InChI KeyOWSREIHFCWEMNW-UHFFFAOYSA-N
Synonym2-Oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1,2-dihydropyridine-3-carbonitrile;3-Pyridinecarbonitrile, 1,2-dihydro-2-oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-
CAS No.2894063-44-4

Synthetic Route by SureRoute

1. ACBFMJ328 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBFMJ328 route product structure diagram
    ACBFMJ3282894063-44-4
Inquiry

2. ACBFMJ328 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBFMJ328 route product structure diagram
    ACBFMJ3282894063-44-4
Inquiry

Comments (0)